Literature DB >> 28364044

High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.

Smriti Murali Krishna1, Sai Wang Seto1,2, Roby Jose1, Jiaze Li1, Joseph Moxon1, Paula Clancy1, David J Crossman3, Paul Norman4, Theophilus I Emeto1,5, Jonathan Golledge6,7.   

Abstract

Abdominal aortic aneurysm (AAA) is a common age-related vascular disease characterized by progressive weakening and dilatation of the aortic wall. Thrombospondin-1 (TSP-1; gene Thbs1) is a member of the matricellular protein family important in the control of extracellular matrix (ECM) remodelling. In the present study, the association of serum TSP-1 concentration with AAA progression was assessed in 276 men that underwent repeated ultrasound for a median 5.5 years. AAA growth was negatively correlated with serum TSP-1 concentration (Spearman's rho -0.129, P=0.033). Men with TSP-1 in the highest quartile had a reduced likelihood of AAA growth greater than median during follow-up (OR: 0.40; 95% confidence interval (CI): 0.19-0.84, P=0.016, adjusted for other risk factors). Immunohistochemical staining for TSP-1 was reduced in AAA body tissues compared with the relatively normal AAA neck. To further assess the role of TSP-1 in AAA initiation and progression, combined TSP-1 and apolipoprotein deficient (Thbs1-/-ApoE-/-, n=20) and control mice (ApoE-/-, n=20) were infused subcutaneously with angiotensin II (AngII) for 28 days. Following AngII infusion, Thbs1-/- ApoE-/- mice had larger AAAs by ultrasound (P=0.024) and ex vivo morphometry measurement (P=0.006). The Thbs1-/-ApoE-/- mice also showed increased elastin filament degradation along with elevated systemic levels and aortic expression of matrix metalloproteinase (MMP)-9. Suprarenal aortic segments and vascular smooth muscle cells (VSMCs) isolated from Thbs1-/-ApoE-/- mice showed reduced collagen 3A1 gene expression. Furthermore, Thbs1-/-ApoE-/- mice had reduced aortic expression of low-density lipoprotein (LDL) receptor-related protein 1. Collectively, findings from the present study suggest that TSP-1 deficiency promotes maladaptive remodelling of the ECM leading to accelerated AAA progression.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Angiotensin II; Low density lipoprotein receptor-related protein 1; Thrombospondin-1; abdominal aortic aneurysm; extracellular matrix; maladaptive remodelling

Mesh:

Substances:

Year:  2017        PMID: 28364044     DOI: 10.1042/CS20160970

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

1.  Role of Thrombospondin-1 in Mechanotransduction and Development of Thoracic Aortic Aneurysm in Mouse and Humans.

Authors:  Yoshito Yamashiro; Bui Quoc Thang; Seung Jae Shin; Caroline Antunes Lino; Tomoyuki Nakamura; Jungsil Kim; Kaori Sugiyama; Chiho Tokunaga; Hiroaki Sakamoto; Motoo Osaka; Elaine C Davis; Jessica E Wagenseil; Yuji Hiramatsu; Hiromi Yanagisawa
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

2.  Myeloid-Derived TSP1 (Thrombospondin-1) Contributes to Abdominal Aortic Aneurysm Through Suppressing Tissue Inhibitor of Metalloproteinases-1.

Authors:  Huan Yang; Ting Zhou; Christine M Sorenson; Nader Sheibani; Bo Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-08       Impact factor: 8.311

3.  Challenges of applying circulating biomarkers for abdominal aortic aneurysm progression.

Authors:  Yuan Li; Dan Yang; Yuehong Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-27

4.  Thrombospondin-1 contributes to slower aortic aneurysm growth by inhibiting maladaptive remodeling of extracellular matrix.

Authors:  Mamoru Satoh; Takahito Nasu; Takuya Osaki; Sho Hitomi
Journal:  Clin Sci (Lond)       Date:  2017-06-07       Impact factor: 6.124

5.  Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm.

Authors:  Sai Wang Seto; Dennis Chang; Hosen Kiat; Ning Wang; Alan Bensoussan
Journal:  Front Cardiovasc Med       Date:  2018-04-20

6.  Lysyl hydroxylase 1 (LH1) deficiency promotes angiotensin II (Ang II)-induced dissecting abdominal aortic aneurysm.

Authors:  Hao Li; Haochen Xu; Hongyan Wen; Hongyue Wang; Ranxu Zhao; Yingying Sun; Congxia Bai; Jiedan Ping; Li Song; Mingyao Luo; Jingzhou Chen
Journal:  Theranostics       Date:  2021-09-21       Impact factor: 11.556

7.  mTOR inhibition prevents angiotensin II-induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice.

Authors:  Changshun He; Bo Jiang; Mo Wang; Pengwei Ren; Sae-Il Murtada; Alexander W Caulk; Guangxin Li; Lingfeng Qin; Roland Assi; Constantinos J Lovoulos; Martin A Schwartz; Jay D Humphrey; George Tellides
Journal:  JCI Insight       Date:  2022-02-08

8.  Discovery of novel biomarkers for atherosclerotic aortic aneurysm through proteomics-based assessment of disease progression.

Authors:  Hiroaki Yagi; Mitsuhiro Nishigori; Yusuke Murakami; Tsukasa Osaki; Sayaka Muto; Yutaka Iba; Kenji Minatoya; Yoshihiko Ikeda; Hatsue Ishibashi-Ueda; Takayuki Morisaki; Hitoshi Ogino; Hiroshi Tanaka; Hiroaki Sasaki; Hitoshi Matsuda; Naoto Minamino
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

Review 9.  AAA Revisited: A Comprehensive Review of Risk Factors, Management, and Hallmarks of Pathogenesis.

Authors:  Veronika Kessler; Johannes Klopf; Wolf Eilenberg; Christoph Neumayer; Christine Brostjan
Journal:  Biomedicines       Date:  2022-01-02

Review 10.  Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment.

Authors:  Daan C H van Dorst; Nathalie P de Wagenaar; Ingrid van der Pluijm; Jolien W Roos-Hesselink; Jeroen Essers; A H Jan Danser
Journal:  Cardiovasc Drugs Ther       Date:  2020-12-07       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.